First-in-Human Exploratory Single Ascending Dose of GLPG0974
Clinical trial NCT01496937 · COMPLETED
Trial details
- NCT number
- NCT01496937
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-01-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.